mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
9e-06 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
1e-05 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |